Find out more about regenerative medicine and AI at the upcoming Knowledge Transfer seminar.

Today, treatments based on laboratory-cultured cells are curing cancer patients. Besides cancer, cell-based therapies have the potential to heal and rejuvenate patients suffering from diseases like Parkinson’s, Alzheimer’s, diabetes and heart disease. In parallel, the technology behind artificial neural networks has made strides in the past years. Jointly, these seemingly unrelated technologies could transform healthcare as we know it. Digital technologies in AI, developed at CERN for high-energy physics, might be promising for this field.

During this seminar, Peter Egelberg, Founder and CEO of Phase Holographic Imaging (PHI), will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.

You are warmly invited to join this discussion in-person or on zoom.

More information: https://indico.cern.ch/e/regenmed.